We are live on ! Find out more
KURA icon

Kura Oncology
KURA

141 hedge funds and large institutions have $885M invested in Kura Oncology in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

20% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 41

3.11% more ownership

Funds ownership: 102.75% → 105.86% (+3.1%)

4% more capital invested

Capital invested by funds: $849M → $885M (+$36.1M)

1% less funds holding

Funds holding: 142 → 141 (-1)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

21% less call options, than puts

Call options by funds: $535K | Put options by funds: $679K

Holders
141
Holders Change
-1
Holders Change %
-0.7%
% of All Funds
2.25%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
15
Increased
49
Reduced
41
Closed
16
Calls
$535K
Puts
$679K
Net Calls
-$144K
Net Calls Change
-$935K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$36.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.1M
3
WP
Woodline Partners
California
+$6.11M
4
Bank of America
Bank of America
North Carolina
+$3.08M
5
BlackRock
BlackRock
New York
+$2.58M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$18.9M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$14.4M
3
State Street
State Street
Massachusetts
-$7.53M
4
Axa
Axa
France
-$3.68M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$2.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
26
Sofinnova Investments
California
$7.54M +$282K +22,608 +4%
SFM
27
Sphera Funds Management
Israel
$7.38M +$562K +45,000 +8%
ACP
28
Acuta Capital Partners
California
$6.91M +$796K +63,757 +13%
JP Morgan Chase
29
JP Morgan Chase
New York
$6.28M -$8.62K -691 -0.1%
Bank of America
30
Bank of America
North Carolina
$6.19M +$3.08M +246,516 +95%
WP
31
Woodline Partners
California
$5.99M +$6.11M +489,532 New
Charles Schwab
32
Charles Schwab
California
$5.76M +$24.4K +1,959 +0.4%
EAM
33
Eagle Asset Management
Florida
$4.59M -$399K -32,007 -8%
ACM
34
Alethea Capital Management
Washington
$4.45M – – –
AAA
35
Affinity Asset Advisors
New York
$4.37M +$1.1M +88,540 +33%
TCM
36
Tekla Capital Management
Massachusetts
$3.46M – – –
Rafferty Asset Management
37
Rafferty Asset Management
New York
$3.36M -$666K -53,364 -16%
Barclays
38
Barclays
United Kingdom
$2.78M +$512K +41,066 +22%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.76M -$63.8K -5,114 -2%
Citigroup
40
Citigroup
New York
$2.7M +$953K +76,397 +53%
UBS Group
41
UBS Group
Switzerland
$2.62M -$9.93K -796 -0.4%
Morgan Stanley
42
Morgan Stanley
New York
$2.58M -$808K -64,746 -23%
Hudson Bay Capital Management
43
Hudson Bay Capital Management
Connecticut
$2.51M +$2.56M +205,000 New
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$2.08M -$96.8K -7,755 -4%
AG
45
Algert Global
California
$1.62M -$366K -29,361 -18%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.53M -$150K -12,000 -9%
ECM
47
ExodusPoint Capital Management
New York
$1.44M +$429K +34,394 +41%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$1.43M – – –
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$1.4M +$567K +45,411 +66%
LOAMS
50
Lombard Odier Asset Management (Switzerland)
Switzerland
$1.39M -$834K -66,826 -37%
1
2
3 4 5

KURA Hedge Fund Activity: Q1 2023 in Review

141 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2023, worth a combined $885M — up 4.2% from $849M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of KURA and 15 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 49 added.

The largest buyer was BVF Inc, adding an estimated $36.6M. The largest seller was Victory Capital Management, exiting entirely with an estimated $18.9M sold.

  • 141 institutional investors held Kura Oncology (KURA) as of Q1 2023, down from 142 in Q4 2022.
  • Funds reported $885M of Kura Oncology stock for Q1 2023, up 4.2% quarter-over-quarter.
  • 15 funds opened new Kura Oncology positions in Q1 2023 and 16 closed out, a net change of -1 holder.
  • The largest Kura Oncology buyer in Q1 2023 was BVF Inc, an estimated $36.6M added.
  • The largest Kura Oncology seller in Q1 2023 was Victory Capital Management, an estimated $18.9M sold.

Based on aggregated 13F filings for Q1 2023.